Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
OTC Markets
22:48:55 08/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.83M 1.72M 1.57M 2.94M 203M 2.95M 20.44M 7.9M 103M 7.99M 7.82M 327M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.8M 5.46M 4.98M 9.31M 642M 9.35M 64.75M 25.03M 327M 25.32M 24.77M 1.04B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +9,900.00% | 0.00% | 2.13K | ||
| +0.92% | -0.49% | -13.17% | +30.70% | 3.44B | ||
| +0.46% | +1.87% | +57.06% | +1,484.30% | 3.13B | ||
| +2.28% | +9.08% | +63.45% | +493.22% | 2.71B | ||
| -0.61% | +1.46% | -29.84% | -13.07% | 1.79B | ||
| -3.54% | -0.52% | +130.12% | +496.88% | 1.53B | ||
| -2.37% | +2.79% | -8.02% | +16.28% | 602M | ||
| +1.77% | +1.33% | +26.11% | +44.30% | 345M | ||
| -1.01% | +4.24% | +46.04% | +56.08% | 209M | ||
| -2.96% | +0.77% | +32.32% | +65.82% | 114M | ||
| Average | -0.51% | +2.99% | +1,020.41% | +267.45% | 1.39B | |
| Weighted average by Cap. | +0.21% | +4.01% | +33.74% | +495.11% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.18M 13.36M 12.17M 22.77M 1.57B 22.86M 158M 61.18M 799M 61.9M 60.55M 2.53B | 14.01M 12.06M 11.35M 10.34M 19.35M 1.33B 19.43M 135M 52M 679M 52.62M 51.47M 2.15B |
| Net income | -4.29M -3.69M -3.48M -3.17M -5.93M -408M -5.95M -41.22M -15.93M -208M -16.12M -15.77M -659M | -7.61M -6.55M -6.16M -5.62M -10.51M -724M -10.55M -73.06M -28.24M -369M -28.57M -27.95M -1.17B |
| Net Debt | 3.04M 2.62M 2.47M 2.25M 4.2M 290M 4.22M 29.22M 11.29M 148M 11.43M 11.18M 467M | 4.62M 3.97M 3.74M 3.41M 6.37M 439M 6.4M 44.32M 17.13M 224M 17.33M 16.95M 709M |
Employees
61
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















